Objective: Human adenovirus Ad-36 causes adiposity in animal models and shows association with human obesity. Ad-36 enhances differentiation of 3T3-L1 and human preadipocytes, without cell lysis, a characteristic that may contribute to its adipogenic effect observed in vivo. Ad-2, another human adenovirus is nonadipogenic in animals and in 3T3-L1 cells and shows no correlation with human obesity. The objective of this study was to determine the adipogenic roles of viral mRNA and DNA, which may explain the differential effects of Ad-36 and Ad-2 on preadipocyte differentiation. Methods: This study determined the duration of selected Ad-36 gene expression in 3T3-L1 cells, and the effect on preadipocytes differentiation, when Ad-36 gene expression was attenuated by Cidofovir, an antiadenoviral agent.
Introduction
A human adenovirus-36 (Ad-36) promotes adiposity in animals and shows association with human obesity. [1] [2] [3] [4] Inoculation of 3T3-L1 preadipocytes with Ad-36, but not Ad-2 (a nonadipogenic human adenovirus), resulted in increased adipocyte number, cellular lipid accumulation and glycerol 3-phosphate dehydrogenase levels (GPDH; an adipocyte differentiation specific enzyme marker) and modulation of several key cellular genes of differentiation. 5 The absence of adipogenic effect of Ad-2 in animals and cells 5, 6 and a lack of association with human obesity 1 suggested that the lipogenic potential is not a common characteristic of all adenoviruses. The lipogenic effect of Ad-36 on preadipocytes may contribute to its adipogenic potential observed in vivo. Understanding the interaction between genes of adipocytes and Ad-36 will help to determine the mechanism involved. Viral entry in a host cell is a likely prerequisite for modulating cellular metabolism. It is necessary to initiate viral replication marked by viral mRNA expression. In permissive cells such as A549 (human lung cancer cell line), adenoviruses express mRNA, replicate their DNA, and produce cell lysis to release nascent virus particles. However, Ad-36 infection of 3T3-L1 preadipocytes is abortive, and cellular metabolism is affected without lysis or cytopathic effect. This suggested that Ad-36 enters 3T3-L1 cells, but its complete replication may not be required for affecting cellular metabolism.
The adenoviral genome consists of a single linear, doublestranded DNA molecule with relatively short terminal repeats and a terminal protein covalently attached to the 5 0 end of the strands. The viral chromosome carries five early transcription units (E1A, E1B, E2, E3, and E4), two delayed early units (IX and IVa2), and one major late unit which when processed generates five families of mRNAs (L1-L5). 24 E1A is the first transcription unit to be expressed, and it is required for activating other viral genes. 7 In this study, we characterized the expression of pertinent adenoviral genes in 3T3-L1 cells. Our first aim was to determine the expression and duration of Ad-36 genes in 3T3-L1 cells, in order to confirm the viral entry and initiation of replication. In addition, we determined whether Ad-2 shows gene expression in 3T3-L1 cells. Next, we hypothesized that Ad-36 gene expression is required for differentiation of preadipocytes. To test the hypothesis, we determined if attenuation of viral gene expression in 3T3-L1 cells by an antiviral will be accompanied by a similar reduction in a key cellular gene of differentiation. Furthermore, as a consequence of reduction in viral gene expression, we expected attenuation of Ad-36-induced lipid accumulation, which was determined in the third experiment.
Materials and methods
Materials used and techniques and assays are described in detail at the end of this section Experiment 1. Characterization of expression of pertinent Ad-36 genes in 3T3-L1 cells Infection of 3T3-L1 and A549 cells with Ad-36. 3T3-L1 cells were grown to confluence in eight 10 cm Petri plates. Six plates were inoculated with Ad-36 at 3.0 multiplicity of infection (MOI), one plate was inoculated with Ad-2 at 2.6 MOI and one plate was inoculated with media (uninfected control). Next, on the same day of inoculation, differentiation was initiated in all plates with 1 mg/ml insulin, 1 mM dexamethazone and 0.5 mM 3-iso-butyl-1-methyl xanthine in Dulbeco's minimum essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (methyl-isobutyl xanthine (MDI); 8, 9 ). After48 h, the cells were switched to a maintenance media containing 1 mg/ml insulin in DMEM and 10% FBS. One plate each with confluent A549 cells were inoculated with Ad-36, Ad-2 or media (uninfected control) as above. RNA was extracted from 3T3-L1 cells on day 0 (3 h postinoculation), and on days 2, 4, 7, 14, and 17 as described under Techniques and assays. RNA was isolated from A549 cells 3 h postinoculation on day 0. The experiment was repeated three times. This RNA was used to determine mRNA levels of viral genes by qualitative reverse transcriptionpolymerase chain reaction (RT-PCR) (data not shown) and real-time PCR assays as described under Techniques and assays.
Expression of genes. Expressions of selected Ad-36 early genes (E1A, E1B, E3, and E4 orf 1) were determined up to 17 days postinoculation in 3T3-L1 cells and on day 0 in A549 cells (positive control). Expression of two late genes of Ad-36, L1 and L2 was determined in A549 and 3T3-L1 cells on day 4 postinoculation. Expression of Ad-2 E1A was determined in 3T3-L1 and A549 cells.
Ad-36 genomic DNA analysis. Six Petri dishes confluent with 3T3-L1 cells were inoculated with Ad-36 (3.8 MOI) and differentiated with MDI. Genomic DNA was extracted on days 0 (3 h postinoculation), 4, 7, 10, 14, and 17 and Realtime PCR analysis of the DNA was performed as described under 'Techniques and assays' using 5-10 ng of DNA and Ad-36 E3 primers. This experiment was repeated three times.
Experiment 2: the effect of Cidofovir on expression of pivotal viral genes and cellular genes participating in preadipocyte differentiation Determination of Cidofovir concentration. A549 cells form plaque when infected with Ad-36, resulting from cellular destruction and death, which is attenuated by Cidofovir. The effective dose of Cidofovir (10 mM) was determined using A549 cells and serial dilutions of the drug ranging from 1 to 1 mM. Ten mM was the lowest drug concentration that blocked the plaque-forming cytopathic effect of Ad-36 (data not presented), while showing least cellular damage as measured by lactate dehydrogenase (LDH) levels as described below.
Antiviral effect of Cidofovir. Plates of A549 cells were divided in four groups and inoculated with Ad-36 or media in the presence or absence of 10 mM Cidofovir, as stated below for 3T3-L1 cells. The LDH concentration in media was determined on day 9 postinoculation as described in the 'Techniques and assays' section. This experiment was repeated using 3T3-L1 cells.
Effect of Cidofovir on gene expression. 3T3-L1 preadipocytes were cultured in DMEM supplemented with 10% FBS and allowed to reach confluence in 4 groups of six-well plates. Two six-well plates each were inoculated with Ad-36 (5 MOI) or media. After 1 h of incubation, one group each from Ad-36 and control received 0 or 10 mM CF in the differentiation media. Thus, there were the following four groups: Ad-36 þ 0 mM CF; Ad-36 þ 10 mM CF; control þ 0 mM CF and control þ 10 mM CF. After 48 h RNA was extracted with RNeasy kit (Qiagen, Volencia, CA, USA, Cat # 74104). Sample RNA concentrations and purity were determined by spectrophotometry. This RNA was used to determine mRNA levels of early viral genes E1A and E4 orf-1, and cellular gene of differentiation CCAAT enhancer binding protein (C/EBP b)
by qualitative RT-PCR and real-time PCR assays as described under 'Techniques and assays' section. On day 5 postinoculation, differentiation of preadipocytes was determined using GPDH method (GPDH; 4), a preadipocyte differentiation specific enzyme marker. On the same day, LDH levels were determined in media to assess cell lysis and toxicity. The GPDH and LDH assays are described in detail in 'Techniques and assays' section. One six-well plate each from the above-mentioned groups was used for determining lipid accumulation by Oil Red O staining. On day 5, media was removed from these wells and the cells were fixed with 10% formaldehyde and stained with lipid specific Oil-Red O dye for 2 h, followed by isopropyl alcohol extraction as described earlier. 5 Absorbance of the alcohol extract was read at 510 nm. Next, these cells were used to isolate DNA using the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA, Cat # A1120). Lipid content of the wells was expressed as the absorbance at 510 nm adjusted to mg DNA content of the well.
Statistical analysis
Values are expressed as means7standard deviation. Independent samples one-tailed t-tests were then conducted. Probability levels were set at alphao0.05. Tissue culture. A549 cells (human bronchial carcinoma cells) (ATCC Cat # CCL-185) and were used for harvesting adenoviruses and 3T3-L1 cells, a murine embryonic preadipocyte cell line (ATCC, Cat # CCL-92-1) were used for the differentiation experiments.
Materials
Virus. Adenovirus-36 was obtained from ATCC (Cat # VR-913) and plaque purified, was used for the experiments. The titer of virus stocks was determined as described previously.
3
Techniques and assays 1. Total RNA isolation. RNA was extracted using TRIZOL reagent (Sigma cat # T-9424) followed by chloroform treatment and RNA precipitation by isopropyl alcohol.
Residual genomic DNA was removed using DNA-Freet (Ambion Cat # 1906). Sample RNA concentrations and purity were determined by spectrophotometry. The integrity of all RNA samples was confirmed by electrophoresis in denaturing formaldehyde-containing gels or Agilent 2100 Bioanalyzer Desktop system (Agilent Technologies, Palo Alto, CA, USA, Cat # G2940CA) using the RNA lab chip (RNA 6000PicoLab chip Kit Cat # 5065-4473).
2. Qualitative RT-PCR. Clontech Titanium One-step RT-PCR kit (Cat # K-1403-2) was used to amplify the viral genes from the total RNA. Each experiment consisted of a positive control with mouse b-actin primers and mouse liver total RNA provided by the kit and a second positive where RNA from Ad-36 infected A549 cells was used. Primers used are described in Table 1 . Each primer set had two negative controls. A no template negative consisted of water instead of RNA and a no RT negative had reverse transcriptase inactivated before the reaction by heating at 951C for 5 min. The RT-PCR conditions were as follows: reverse transcription was performed for 1 h at 501C followed by 35 cycles of denaturation for 30 s at 941C annealing for 30 s at 551C extension 1 min at 681C and final extension 1 min at 681C The samples were run on a 1% agarose gel containing 0.005% ethidium bromide, at 80 V for 2 h in TAE (Tris-acetate EDTA) buffer. The samples were loaded on to the gel with 6 Â loading Dye (Promega Cat # G-1881). The bands were visualized in Bio-Rad Chemi-Imager under UV lamp.
3. Quantitative (real-time) RT-PCR. iCycler iQ real-time PCR detection system (Bio-Rad Cat # 170-8740) was used for quantification of the viral genes. b-Actin was used as an internal standard for each sample as well as for the preparation of standard curve. The quantification of each gene was performed relative to the quantity expressed on day 0 as well as relative to b-actin expression on each day of the time course.
cDNA synthesis
The iscriptt cDNA synthesis kit (Bio-Rad Cat # 170-8890) was used for cDNA synthesis using 1 mg of total RNA. Manufacturer's suggested protocol was followed for the cDNA synthesis. One ml of the resultant cDNA was used for real-time PCR.
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Real-time PCR iQt SYBR Green Supermix (Bio-Rad Cat # 170-8880) was used for real-time analysis. Primers used are described in Table 1 . Each sample was prepared in triplicate and each sample had a triplicate of internal control b-actin prepared simultaneously. The assays were run simultaneously on 96-well optical reaction plates. The PCR protocol consisted of an initial denaturation of 3 min at 941C, followed by 35 cycles of 30 s denaturation at 941C, 1 min annealing at 581C, and 30 s extension at 681C. The end point used in the real-time PCR quantification, C t, is defined as the PCR cycle number that crosses an arbitrarily placed signal threshold. The amount of mRNA for the genes of interest relative to b-actin was calculated as 2 ÀDCt where
4. Isolation of genomic DNA. The cells were washed gently with PBS and lysed by freezing and thawing for DNA extraction. Cellular genomic DNA was isolated using the Wizard Genomic DNA isolation kit (Promega Cat # A1620). The quality and quantity of the DNA was measured spectrophotometrically. Changes in the viral DNA concentration were determined by real-time PCR assay for E3, one of the viral genes. Primers used for this assay are described in Table 1 .
5. Glycerol-3-phosphate dehydrogenase assay. GPDH was measured using the method of Weiss and Green. 10 The assay involves generation of glycerol 3-phosphate from dihydroxyacetone phosphate (DHAP) by GPDH, using NADH as coenzyme. Glycerol 3-phosphate dehydrogenase from rabbit muscle (Sigma Cat # G-6880) was used to construct a standard curve. The enzyme was expressed as mU enzyme per mg of protein extracted from 3T3-L1 cells (modified Lowry protein assay kit; Fischer Cat # P123240).
6. Lactate dehydrogenase assay. The LDH assay was used as a method of measuring cell toxicity as a function of the amount of cytoplasmic LDH released into the medium. It is based on the reduction of NAD by the action of LDH. The resulting reduced NADH is utilized in the stoichiometric conversion of tetrazolium dye. The resulting colored compound was measured spectrophotometrically. 11, 12 The total LDH was measured from the supernatant (1:100 dilution) using in vitro toxicology assay kit (Sigma Cat # TOX-7). The absorbance was read at 490 nm.
Results
Experiment 1. Characterization of expression of pertinent Ad-36 genes in 3T3-L1 cells Infection of 3T3-L1 and A549 cells with Ad-36. Cellular mRNA samples with no DNA contamination and with no degradation of RNA, as determined by the Agilent 2100 BioAnalyzer system were used for gene expression experiments. Expression levels of Ad-36 E1A, E1B, E3 and E4-orf1 over a period of 17 days were compared relative to b-actin by realtime PCR (Figure 1) . Expression for these genes was transient, which peaked between days 2-4 postinfection and very low level expression was seen on day 7 postinoculation. Adenovirus-36 late genes (L1 and L2) expression was verified on day 4 by qualitative RT-PCR (Figure 2) .
Expression of Ad-2 E1A was noted in A549 cells, but not in 3T3-L1 cells (Figure 3) . Absence of Ad-2 E1A expression in Experiment 2. The effect of Cidofovir on expression of pivotal viral genes and cellular genes participating in preadipocyte differentiation Antiviral effect of Cidofovir. Four groups of A549 cells were used for the experiment. Two groups were infected with Ad-36 and the remaining two groups were uninfected controls. One group each from the control and the infected were treated with Cidofovir.
In the absence of Cidofovir, the infected group had significantly greater LDH secretion in the media, compared to the control (Po0.05) 9 days postinoculation (Table 2) . However, in the presence of Cidofovir, LDH did not differ in the infected and the uninfected groups.
Lactate dehydrogenase measured from the supernatant of 3T3-L1 cells showed no difference between the infected and the control groups in the presence or absence of Cidofovir (Table 3 ). These data showed that neither the virus, nor the drug had cytopathic effect on 3T3-L1 cells.
Effect of Cidofovir on gene expression. Expressions of two early viral genes, E4-orf 1 and E1A 13 S and one cellular gene of In the absence of Cidofovir, the infected group had significantly greater LDH secretion in the media, compared to the control (Po0.05) 9 days postinoculation. In the presence of Cidofovir, LDH did not differ in the infected and the uninfected groups.
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M Rathod et al differentiation, C/EBP b, were studied in 3T3-L1 cells. Cellular mRNA was isolated 48 h postinfection and the purity and integrity of the RNA was confirmed spectrophotometrically. Comparison of the RT-PCR products show that as expected, the viral genes E4-orf1 and E1A 13S were expressed only in the Ad-36 infected groups and not in the uninfected controls ( Figure 5 ). C/EBP b was expressed in uninfected and Ad-36 infected 3T3-L1 cells, but the Ad-36 infected group showed greater expression. Expressions of the viral genes and C/EBP b were attenuated in the presence of Cidofovir ( Figure 5 ). b-Actin was used as an internal positive control. The results were confirmed with no template negative control and no reverse transcriptase samples (data not shown). Attenuation of expression of E4 orf1 and C/EBP b was quantitated by real-time PCR (Figure 6 ), and was lower in the presence of Cidofovir (P ¼ 0.052 and 0.058, respectively).
Experiment 3. The effect of Cidofovir on Ad-36-induced preadipocyte differentiation in 3T3-L1 cells Figure 7 shows GPDH enzyme and lipid accumulation (as determined by Oil Red O absorbance) on day 5 postinoculation. As expected, the Ad-36 inoculated group showed greater differentiation compared to the uninfected control and the differentiation was attenuated by Cidofovir. Glycerol 3-phosphate dehydrogenase and Oil Red O absorbance were significantly greater in Ad-36 infected group (P ¼ 0.002 and 0.02, respectively). Glycerol 3-phosphate dehydrogenase or Four group of 3T3-L1 cells were used for the experiment. Two groups were infected with Ad-36 and the remaining two groups were uninfected controls. One group each from the control and the infected were treated with Cidofovir. LDH (mU) measured from the supernatant of the differentiated cells showed no difference between the infected and the control groups in presence or absence of Cidofovir. Abbreviations: Ad-32, adenovirus-2; LDH, lactate dehydrogenase. Cidofovir. Data show the (mean7s.e.) Â 10 2 mU of GPDH enzyme and lipid content as determined by the absorbance of oil red o extraction at (510 nm/ mg DNA) on day 5 after differentiation. The Ad-36 infected groups were inoculated with five multiplicity of infection (MOI) of Ad-36. n ¼ 12 wells per group. * and **: GPDH and Oil Red O absorbance were significantly greater in Ad-36 infected group compared to the uninfected control (P ¼ 0.002 and 0.02, respectively). GPDH or Oil Red O absorbance of the 'Ad-36 þ Cidofovir' group did not show significantly greater difference vs the uninfected controls. *** GPDH levels in 'Cidofovir þ Ad-36' group were significantly attenuated vs the Ad-36 group (Po0.02). Differentiation in Cidofovir group (without Ad-36) did not differ from that in the uninfected control.
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Oil Red O absorbance of the 'Ad-36 þ Cidofovir' group did not show significantly greater difference vs the uninfected controls. Glycerol 3-phosphate dehydrogenase levels in 'Cidofovir þ Ad-36' group were significantly attenuated vs the Ad-36 group (Po0.02). Differentiation in Cidofovir group (without Ad-36) did not differ from that in the uninfected control.
Discussion
Infections and adiposity Over the past two decades, 10 pathogens have been implicated in obesity in experimental animal models (Review -Dhurandhar et al. 13 ). Of these, SMAM-1, an avian adenovirus was the first to show an association with human obesity 14 and Ad-36, a human adenovirus was the first human virus reported to cause adiposity in animal models and show association with human obesity. [1] [2] [3] [4] As these initial reports, adipogenic potentials of more human adenoviruses, Ad-37 and Ad-5, have been reported. 6, 15 Potential of various human adenoviruses to increase preadipocyte differentiation and cause adiposity may vary. Adenovirus-36, Ad-31, and Ad-37 increase rodent preadipocyte differentiation, 6 but Ad-31
is not associated with human obesity and the association of Ad-37 with human obesity is unclear. 1 Therefore, Greenway 16 recommended development of an in vitro assay that would correlates with association with human obesity for screening of adenovirus serotypes for their potential to induce human obesity. Nevertheless, considering the ubiquitous nature of naturally occurring adenovirus infections and their extensive use as vectors in gene delivery, understanding their adipogenic potential is critical.
Adenoviruses -background
Adenoviruses are naked DNA viruses with icosahedral symmetry and a diameter of 65-80 nm. In humans, adenoviruses are frequently associated with acute upper respiratory tract infections, and may cause enteritis or conjunctivitis. Adenoviruses can easily be isolated from nasal swabs or from feces. Adenovirus infections are transmitted via respiratory, fomite, droplet, venereal, and fecal-oral routes. So far 50 human adenovirus serotypes have been identified. Based on hemagglutination properties and crossreactivity to antisera, these have been classified in to six sub groups; A-F. Adenovirus type-36 belongs to subgroup D along with Ad-9 and Ad-37. Adenovirus type-2 (Ad-2) belongs to subgroup C and is the most common adenovirus. Characterization of expression of pertinent Ad-36 genes in 3T3-L1 cells Adenoviral early genes code for functional proteins while the late genes code for structural proteins. We hypothesized that one or more of the early gene products may be involved in the upregulation of preadipocyte differentiation. E2 gene products are not known to interact with cellular genes. 17 Therefore, we focused on determining the expression of Ad-36 E1A, E1B, E3, and E4 (ORF-1), in 3T3-L1 cells. As expected, A549 and 3T3-L1 cells expressed E1A mRNA at 3 h postinoculation, confirming the entry of Ad-36 in to 3T3-L1 cells and the initiation of viral replication process. All four genes studied, E1A, E1B, E3, and E4, showed maximal expression between the days 2 and 4 postinfection which coincides with the time period of maximal differentiation enhancement by Ad-36 in 3T3-L1 cells. 5 This indicated a possible role of viral genes in upregulating adipogenesis, which was confirmed by blocking the expression with antiviral agent, Cidofovir. The expression pattern of the viral genes did not allow identification of a specific candidate in differentiation enhancement. Steady decline in the quantity of Ad-36 DNA in infected 3T3-L1 cells indicated a failure of the virus to replicate its genome. This observation is consistent with the lack of cell lysis (CPE) in 3T3-L1 cells. In permissive cells, viral DNA replication occurs simultaneous with late gene expression. 19, 20 Therefore, inability of Ad-2 to replicate in 3T3-L1 cells is not surprising.
Effect of Cidofovir on gene expression
Cidofovir is perhaps the most effective antiadenoviral agents, 21, 22 which has been used to treat infections of adenoviruses like type 5. 23, 24 Cidofovir also has a broad spectrum of activity against other viruses such as human herpes virus, adenovirus, polyomavirus, and human poxviruses. 25 Cidofovir was effective against all six species of human adenovirus at 17-81 mM, 21 a dose very similar to 10 mM used in this study. We opted for the lowest drug dose that blocked the virus without damaging cells. Lactate dehydrogenase was used as an indicator of cell damage induced by the drug or the virus. As Ad-36 replicates and induces cytopathic changes in A549 cells, as expected, these cells showed greater LDH due to viral damage, which was attenuated in the presence of Cidofovir. Lack of increase in LDH in Ad-36 infected 3T3-L1 cells indicated a lack of cytopathic effect of the virus. Therefore, unlike the A549 cells, LDH attenuation was not a useful marker for determining the effect of Cidofovir on Ad-36 infection in 3T3-L1 cells. Instead, the effect of Cidofovir on Ad-36 infection in 3T3-L1 cells was best determined by attenuation in viral mRNA expression, which was also accompanied by a decrease in C/ EBP b expression, a pivotal transcription factor in adipocyte differentiation pathway. 26 Reduction in C/EBP b expression suggests its dependency on viral gene expression. However, it may be argued that the presence of Cidofovir itself reduced C/EBP b expression and may lead to reduced differentiation. These questions were answered by Experiment 3 as explained below.
Effect of Cidofovir on adipocyte differentiation
Glycerol 3-phosphate dehydrogenase is an enzyme specific for adipocyte differentiation and extensively used as a marker for the same. 19, 27, 28 In conformity with earlier reports 5 differentiation of preadipocytes, as indicated by GPDH activity was significantly greater in Ad-36 infected 3T3-L1 cells compared to the uninfected controls. It was noteworthy that the cell differentiation in the presence of Cidofovir was similar to that in the uninfected controls. This further indicated the absence of any adverse effect of the drug on cells, or on their differentiation potential. As hypothesized, Cidofovir attenuated differentiation induced by Ad-36. Taken together, these experiments demonstrate that the adipogenic human adenovirus Ad-36 does enter 3T3-L1 preadipocytes and initiates its replication, which however, does not lead to new virus assembly. Peak expression of Ad-36 mRNA is seen between 2 and 4 days postinoculation, which also coincides with its effect on preadipocytes differentiation. 5 Requirement of viral mRNA for its effect on preadipocytes differentiation was demonstrated in two ways. Adenovirus type-2 mRNA was not detected in 3T3-L1 cells, which may explain the lack of its adipogenic effect. On the other hand, attenuation in Ad-36-induced preadipocytes differentiation was observed when Ad-36 mRNA expression was reduced by Cidofovir. Thus, the preadipocytes differentiation promoting effect of Ad-36 required its mRNA expression. Most importantly, DNA replication or a constant Ad-36 mRNA expression was not required for the effect. The adipogenic effect of Ad-36 even after transient mRNA expression suggests that Ad-36 may act in 'hit and run' fashion as in case of Canine Distemper virus, 29 which causes obesity in mice, without a continuous presence in the animal. Regulation of preadipocytes differentiation by gene expression of a human adipogenic virus is an important phenomenon, which may provide insights in novel regulatory controls of cell replication and differentiation. Additionally, this work will provide the basis to elucidate the role of various Ad-36 genes contributing to the phenomenon as well as to determine the etiological role, if any, of the virus in certain subgroup of human obesity.
